Navigation Links
AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY'
Date:8/23/2007

This news release includes "forward looking statements" of AspenBio Pharma, Inc. ("APNB") as defined by the Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical fact, included in the press release that address activities, events or developments that APNB believes or anticipates will or may occur in the future are forward- looking statements. These statements are based on certain assumptions made based on experience, expected future developments and other factors APNB believes are appropriate in the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of APNB. Investors are cautioned that any such statements are not guarantees of future performance. Actual results or developments may differ materially from those projected in the forward-looking statements as a result of many factors, including the ability to successfully complete the development of new products, execute agreements required to successfully advance the company's objectives, retain the scientific management team to advance the products, obtain additional funding as and if needed, adverse changes in market conditions and the regulatory environment, fluctuations in sales volumes, the realization of intangible assets and meeting continued listing requirements of NASDAQ. Furthermore, APNB does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this news release should be considered in conjunction with the warnings and cautionary statements contained in APNB's recent filings with the SEC.

For more information contact:

AspenBio Pharma, Inc.

Greg Pusey, Chairman

303-722-4008

Investor Relations:

Liolios Group, Inc.

Scott Liolios or Ron Both

949-574-3860


'/>"/>
SOURCE AspenBio Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015 Cutting-edge biotech & ... nutrition products reveal technological advancements are in growing ... as hyperglycemia, obesity, insulin level issues and other ... Companies in focus today are: RiceBran Technologies (NASDAQ: ... ANFI ), CEL-SCI Corporation (NYSE: ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Sterlitech is ... flat-sheet testing system at the 2015 AMTA Membrane Technology ... culmination of a decade’s worth of engineering and customer ... with a wide range of applications across an array ... enough to meet the dynamic needs of researchers and ...
(Date:2/28/2015)... Increasing its efforts to resolve the GMO Controversy ... of The GMO TRUTH podcast on both ITunes and at ... its mission to discover the truth and change the world. ... the truth about the GMOs in our food supply,” adds ... is an expansion of the documentary/investigative film-making methodology in place ...
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
Breaking Biology Technology:Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7Sterlitech Displays Complete CF042 Membrane Test System 2The Walk a Mile Project Launches “GMO Truth” Podcast 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4
... Oct. 10 DermTech International, Inc.,a biotechnology ... early,detection of melanoma and other diseases, today ... Advisory Board. Dr. Quackenbush is a,Professor of ... Institute and Professor of Computational Biology and ...
... For Hispanic-Americans without health,insurance, it can be difficult ... prescription medicines. However, help is available for people,who ... doctors. Listen to this report from Pfizer ... Registered journalists can access video, audio, text, graphics ...
... MISSISSAUGA, ON, Oct. 9 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ... the,third quarter of 2007. All dollar amounts referenced herein ... 31, 2007, our cash and cash equivalents and restricted ... 31, 2007. With,the repayment of our convertible notes during ...
Cached Biology Technology:DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Company's Scientific Advisory Board 2Vasogen Announces Third Quarter 2007 Results 2Vasogen Announces Third Quarter 2007 Results 3Vasogen Announces Third Quarter 2007 Results 4Vasogen Announces Third Quarter 2007 Results 5Vasogen Announces Third Quarter 2007 Results 6Vasogen Announces Third Quarter 2007 Results 7Vasogen Announces Third Quarter 2007 Results 8Vasogen Announces Third Quarter 2007 Results 9Vasogen Announces Third Quarter 2007 Results 10Vasogen Announces Third Quarter 2007 Results 11Vasogen Announces Third Quarter 2007 Results 12Vasogen Announces Third Quarter 2007 Results 13
(Date:3/2/2015)... , March 2, 2015 Synaptics Inc. ... of human interface solutions, today announced a new ... designed to enable rapid and secure transactions and ... for gaming is a turnkey solution providing mouse ... to quickly integrate fingerprint ID solutions into their ...
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
(Date:3/2/2015)...   Neurotechnology , a provider of high-precision biometric, ... Software Development Kit (SDK). The SentiGaze algorithm enables ... webcams to track eye movements and generate heatmaps based ... can be used for applications such as analysis of ... SDK can also be used to develop interfaces for ...
Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Personal Data Protection Company Launches New Product 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... Tri-Band WLAN Module in SDIO Card Form Factor, ... today,announced the SX-SDWAG, the first world,s first wireless ... form factor. Designed for,wireless local area network (WLAN) ... ideal for battery-operated portable devices in,the medical, weights ...
... consolidating world databases of ocean organisms have demoted ... culled from 34 regional and highly specialized inventories. ... ( www.marinespecies.org ) contains about 122,500 validated marine ... some 56,400 aliases 32% of all names ...
... Calif.) Michael Gazzaniga, professor of psychology at UC ... the Study of the Mind, has received the Humboldt ... "Professor Gazzaniga is a true pioneer in reaching ... the relationship between mind and brain," said UCSB Chancellor ...
Cached Biology News:Silex Introduces SX-SDWAG 802.11a/b/g SDIO Radio Card for OEM Portable Device Applications 2Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 2Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 3Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 4Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 5Neuroscientist Michael Gazzaniga awarded Humboldt Prize 2
This application changes sensitive keywords in an FCS file to remove patient information. It was contributed by Dr. David Miller....
... Killer Cell Receptor-P1, clone 1C10 ... Hybridoma produced by the ... mice immunized (BALB/c X C57BL/6)F1 ... and mouse myeloma cellline. ...
Phospho-SEK1/MKK4 (Thr261) Antibody...
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
Biology Products: